| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Anthracycline cardiotoxicity in survivors of childhood cancer: Clinical course, protection, and treatment
|
Bansal, Neha
|
|
2014
|
36 |
1-2 |
p. 11-18
8 p.
|
article
|
| 2 |
A review of the preclinical development of dexrazoxane
|
Herman, Eugene H.
|
|
2014
|
36 |
1-2 |
p. 33-38
6 p.
|
article
|
| 3 |
Balancing cancer treatment efficacy with the risk of cardiotoxicity and strategies for cardioprotection in adults
|
Melloni, Chiara
|
|
2014
|
36 |
1-2 |
p. 61-63
3 p.
|
article
|
| 4 |
Balancing the oncologic effectiveness versus the cardiotoxicity of anthracycline chemotherapy in childhood cancer
|
Colan, Steven D.
|
|
2014
|
36 |
1-2 |
p. 7-10
4 p.
|
article
|
| 5 |
Cardiotoxicity in adults: An update
|
Ewer, Michael S.
|
|
2014
|
36 |
1-2 |
p. 57-59
3 p.
|
article
|
| 6 |
Dexrazoxane for reducing anthracycline-related cardiotoxicity in children with cancer: An update of the evidence
|
Lipshultz, Steven E.
|
|
2014
|
36 |
1-2 |
p. 39-49
11 p.
|
article
|
| 7 |
Editorial Board
|
|
|
2014
|
36 |
1-2 |
p. ii-
1 p.
|
article
|
| 8 |
How do we improve the long-term consequences of cardiotoxicity in survivors of childhood cancer?
|
Steiner, Rudolf K.
|
|
2014
|
36 |
1-2 |
p. 27-30
4 p.
|
article
|
| 9 |
Late cardiotoxicity in aging adult survivors of childhood cancer
|
Armstrong, Gregory T.
|
|
2014
|
36 |
1-2 |
p. 19-26
8 p.
|
article
|
| 10 |
Lessons from the hearts of survivors of childhood cancer
|
Vrooman, Lynda M.
|
|
2014
|
36 |
1-2 |
p. 51-55
5 p.
|
article
|
| 11 |
New frontiers in Cardio-Oncology
|
Carver, Joseph
|
|
2014
|
36 |
1-2 |
p. 1-2
2 p.
|
article
|
| 12 |
Opportunities to meet clinical cardio-oncology needs with new approaches to non-clinical safety assessment
|
Berridge, Brian R.
|
|
2014
|
36 |
1-2 |
p. 31-32
2 p.
|
article
|
| 13 |
What is cardiotoxicity?
|
Yeh, Edward T.
|
|
2014
|
36 |
1-2 |
p. 3-6
4 p.
|
article
|
Journal description